Penthrox approved in EUSEM guidelines
24 October 2019
ASX Announcement
Penthrox® entered in the European Society of Emergency Medicine (“EUSEM”) guidelines as now being recommended and approved as “first-line of treatment” trauma medication.
Medical Developments International Ltd (ASX: MVP) is delighted to announce that Penthrox has been included in the new EUSEM guidelines for the “Management of acute pain in emergency situations”. These new guidelines are published on the EUSEM website and can be found at: https://eusem.org/education/guidelines. The Guidelines cover all aspects of acute pain management in emergency situations across Europe.
For further details please click on the following link – Penthrox approved in EUSEM guidelines